Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16,253 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tolvaptan and urea in paediatric hyponatraemia.
Veligratli F, Alexandrou D, Shah S, Amin R, Dattani M, Gan HW, Famuboni A, Lopez-Garcia C, Trompeter R, Bockenhauer D. Veligratli F, et al. Among authors: shah s. Pediatr Nephrol. 2024 Jan;39(1):177-183. doi: 10.1007/s00467-023-06091-w. Epub 2023 Jul 19. Pediatr Nephrol. 2024. PMID: 37466863 Review.
Cerebrovascular damage caused by the gut microbe/host co-metabolite p-cresol sulfate is prevented by blockade of the EGF receptor.
Shah SN, Knausenberger TB, Pontifex MG, Connell E, Le Gall G, Hardy TAJ, Randall DW, McCafferty K, Yaqoob MM, Solito E, Müller M, Stachulski AV, Glen RC, Vauzour D, Hoyles L, McArthur S. Shah SN, et al. Gut Microbes. 2024 Jan-Dec;16(1):2431651. doi: 10.1080/19490976.2024.2431651. Epub 2024 Nov 24. Gut Microbes. 2024. PMID: 39582109
Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study.
Ferrante M, D'Haens G, Jairath V, Danese S, Chen M, Ghosh S, Hisamatsu T, Kierkus J, Siegmund B, Bragg SM, Crandall W, Durand F, Hon E, Lin Z, Lopes MU, Morris N, Protic M, Carlier H, Sands BE; VIVID Study Group. Ferrante M, et al. Lancet. 2024 Nov 21:S0140-6736(24)01762-8. doi: 10.1016/S0140-6736(24)01762-8. Online ahead of print. Lancet. 2024. PMID: 39581202
Cognitive Impairment is common and unrecognized in vascular surgery patients.
Draper EJ, Nguyen TB, Mirzaie AA, Neal D, Scali ST, Huber TS, Berceli SA, Upchurch GR Jr, Shah SK. Draper EJ, et al. Among authors: shah sk. Ann Vasc Surg. 2024 Nov 21:S0890-5096(24)00691-5. doi: 10.1016/j.avsg.2024.11.003. Online ahead of print. Ann Vasc Surg. 2024. PMID: 39580029
Intravenous glibenclamide for cerebral oedema after large hemispheric stroke (CHARM): a phase 3, double-blind, placebo-controlled, randomised trial.
Sheth KN, Albers GW, Saver JL, Campbell BCV, Molyneaux BJ, Hinson HE, Cordonnier C, Steiner T, Toyoda K, Wintermark M, Littauer R, Collins J, Lucas N, Nogueira RG, Simard JM, Wald M, Dawson K, Kimberly WT; CHARM Trial investigators. Sheth KN, et al. Lancet Neurol. 2024 Dec;23(12):1205-1213. doi: 10.1016/S1474-4422(24)00425-3. Lancet Neurol. 2024. PMID: 39577921 Clinical Trial.
16,253 results
You have reached the last available page of results. Please see the User Guide for more information.